Laurion Capital Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Laurion Capital Management’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-66,149	Closed	-$1.79M	–	640
2024 Q2	$1.79M	Sell	66,149 -2,406	-4%	-$47.4K	0.02%	239
2024 Q1	$1.48M	Buy	68,555 +46,645	+213%	+$1.02M	0.01%	352
2023 Q4	$132K	Sell	21,910 -4,568	-17%	-$22.8K	﹤0.01%	437
2023 Q3	$147K	Sell	26,478 -4,440	-14%	-$28.6K	﹤0.01%	437
2023 Q2	$227K	Hold	30,918	–	–	﹤0.01%	476
2023 Q1	$122K	Buy	30,918 +10,000	+48%	+$48.8K	﹤0.01%	397
2022 Q4	$66.1K	Hold	20,918	–	–	﹤0.01%	390
2022 Q3	$78K	Hold	20,918	–	–	﹤0.01%	453
2022 Q2	$65K	Hold	20,918	–	–	﹤0.01%	411
2022 Q1	$109K	Hold	20,918	–	–	﹤0.01%	492
2021 Q4	$101K	Hold	20,918	–	–	﹤0.01%	512
2021 Q3	$186K	Hold	20,918	–	–	﹤0.01%	640
2021 Q2	$191K	Sell	20,918 -3,482	-14%	-$34.7K	﹤0.01%	652
2021 Q1	$398K	Buy	+24,400	New	+$399K	﹤0.01%	619

Other funds holding LBPH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Laurion Capital Management's LBPH Position: Q3 2024 in Review

Laurion Capital Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q3 2024, closing a stake of 66,149 shares — an estimated $1.79M sold.

Laurion Capital Management first reported a position in LBPH in Q1 2021 and held it in 14 quarters. The position peaked at $1.79M in Q2 2024. 125 funds tracked by Wall St. Rank hold LBPH as of Q3 2024.

Laurion Capital Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Laurion Capital Management sold 66,149 Longboard Pharmaceuticals, Inc. Common Stock shares in Q3 2024, an estimated $1.79M.
Laurion Capital Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 14 quarters.
Laurion Capital Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $1.79M in Q2 2024.
125 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q3 2024.

Based on Laurion Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.